Myomo (MYO) Cash from Operations (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 79.37% |
| Jun 30, 2025 | -231.18% |
| Mar 31, 2025 | -179.53% |
| Dec 31, 2024 | 325.26% |
| Sep 30, 2024 | 22.01% |
| Jun 30, 2024 | 40.97% |
| Mar 31, 2024 | -37.77% |
| Dec 31, 2023 | -37.38% |
| Sep 30, 2023 | -500.58% |
| Jun 30, 2023 | 84.28% |
| Mar 31, 2023 | 26.28% |
| Dec 31, 2022 | 11.95% |
| Sep 30, 2022 | -5.69% |
| Jun 30, 2022 | -14.01% |
| Mar 31, 2022 | -27.02% |
| Dec 31, 2021 | 17.60% |
| Sep 30, 2021 | 34.49% |
| Jun 30, 2021 | -60.33% |
| Mar 31, 2021 | -86.49% |
| Dec 31, 2020 | 37.06% |
| Sep 30, 2020 | 50.75% |
| Jun 30, 2020 | -49.49% |
| Mar 31, 2020 | 7.53% |
| Dec 31, 2019 | -15.45% |
| Sep 30, 2019 | -0.12% |
| Jun 30, 2019 | 26.68% |
| Mar 31, 2019 | -24.15% |
| Dec 31, 2018 | -1.21% |
| Sep 30, 2018 | -5.88% |
| Jun 30, 2018 | -3.52% |
| Mar 31, 2018 | -46.90% |
| Dec 31, 2017 | 17.28% |
| Sep 30, 2017 | -17.60% |
| Jun 30, 2017 | -36.45% |
| Mar 31, 2017 | -28.53% |
| Dec 31, 2016 | 31.23% |